ArticleFrontiers in oncology2025

Remarkable response to pembrolizumab in PD-L1 overexpressing (≥ 50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: a case report.

Yong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.